Recombinant rabies virus for expressing canine distemper virus structural protein and application of recombinant rabies virus
A technology of rabies virus and canine distemper virus, which is applied in the field of immunology, veterinary biopharmaceuticals, and genetic engineering, can solve problems such as incomplete control, achieve high levels of neutralizing antibodies, easy mass production, and high expression levels of foreign proteins Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the examples are all in accordance with conventional experimental conditions, such as Sambrook et al. Molecular Cloning Experiment Manual (Sambrook J & Russell DW, Molecular Cloning: a Laboratory Manual, 2001), or in accordance with the conditions suggested by the manufacturer's instructions. The construction of the recombinant rabies virus of embodiment 1 expression canine distemper virus fusion protein (F) and canine distemper virus hemagglutinin protein (H)
[0047] 1. Materials
[0048] 1.1 Plasmids, cells and antibodies
[0049] The full-length infectious clone plasmid of rabies virus and BSR cells were preserved by Changchun Sino Biotechnology Co., Ltd. FITC-labeled mouse anti-RABV N protein monoclonal antibody was purchased from FDI FUJIREBIO; goat anti-CDV polyclonal was purchased from VMRD; FITC-lab...
Embodiment 2
[0104] Example 2 BHK cell suspension culture recombinant virus
[0105] 1. Materials
[0106] 1.1 Virus: Recombinant rabies virus SRV9-CDVH, SRV9-CDVF, constructed from Example 1.
[0107] 1.2 Cells: BHK suspension cells and NA cells were identified and preserved by Changchun Sino Biotechnology Co., Ltd.
[0108] 1.3 Medium: DMEM medium was purchased from Corning Company, and CD BHK-21 medium was purchased from Gbico Company.
[0109] 2. Method
[0110] 2.1 Growth curve of recombinant virus in BHK cells in vitro
[0111] Infect BHK suspension cells with recombinant viruses SRV9-CDVH and SRV9-CDVF according to MOI=0.5 and MOI=1, respectively, at 37°C, 5% CO 2 , 120rpm conditions, during the culture period, virus supernatant samples were collected at 24 hours, 48 hours, 72 hours, 96 hours, and 120 hours to detect virus titers and draw virus growth curves.
[0112] Infect BHK suspension cells with the recombinant virus SRV9-CDVH and SRV9-CDVF according to MOI=1, at 37°C, 5...
Embodiment 3
[0119] The genetic stability research of embodiment 3 recombinant virus SRV9-CDVH, SRV9-CDVF exogenous gene
[0120] 1. Materials
[0121] 1.1 Virus: Recombinant rabies virus SRV9-CDVH, SRV9-CDVF, constructed from Example 1.
[0122] 1.2 Cells: BHK suspension cells, identified and preserved by Changchun Sino Biotechnology Co., Ltd.
[0123] 1.3 Medium: CD BHK-21 medium was purchased from Gbico.
[0124] 2. Method
[0125] According to the sequence information of the inserted CDV-H and CDV-F-TMCD genes in the recombinant virus genome, a pair of specific primers were designed for RT-PCR identification using PrimerPremier software. The primer sequences are shown in Table 4. Take the SRV9-CDVH, SRV9-CDVF recombinant rabies virus of the F2 generation, F4 generation, F6 generation, F8 generation, F10 generation, F12 generation, F14 generation, F16 generation, F20 generation, F24 generation and F28 generation, and carry out RNA extraction. After reverse transcription, use cDNA to...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com